Non-Current Assets

Buildings and improvements

Merck & Co. Buildings and improvements increased by 9.9% to $17.98B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 9.9%, from $16.36B to $17.98B. Over 5 years (FY 2020 to FY 2025), Buildings and improvements shows an upward trend with a 8.4% CAGR.

Analysis

StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2014
Last reportedQ4 2025Feb 24, 2026
Parent metricPP&E (Net)

How to read this metric

Increases indicate ongoing investment in physical capacity, while decreases reflect depreciation or the divestiture of facilities.

Detailed definition

The book value of buildings and leasehold improvements used for operations. This reflects the company's investment in it...

Peer comparison

Benchmark against peers based on the capital intensity of their manufacturing and R&D footprint.

Metric ID: ppe_buildings

Historical Data

5 periods
 Q4 '21Q4 '22Q4 '23Q4 '24Q4 '25
Value$12.53B$13.17B$14.97B$16.36B$17.98B
QoQ Change+5.1%+13.7%+9.3%+9.9%
YoY Change+5.1%+13.7%+9.3%+9.9%
% of PP&E (Net)65.0%61.5%64.9%68.8%71.0%
Share Change-3.5pp+3.5pp+3.9pp+2.2pp
Range$12.53B$17.98B
CAGR+43.5%
Avg YoY Growth+9.5%
Median YoY Growth+9.6%
Current Streak4+ quarters growth

Frequently Asked Questions

What is Merck & Co.'s buildings and improvements?
Merck & Co. (MRK) reported buildings and improvements of $17.98B in Q4 2025.
How has Merck & Co.'s buildings and improvements changed year-over-year?
Merck & Co.'s buildings and improvements increased by 9.9% year-over-year, from $16.36B to $17.98B.
What is the long-term trend for Merck & Co.'s buildings and improvements?
Over 5 years (2020 to 2025), Merck & Co.'s buildings and improvements has grown at a 8.4% compound annual growth rate (CAGR), from $12.00B to $17.98B.
What does buildings and improvements mean?
The value of the company's buildings and facility improvements.